Search - tctmd.com

Displaying 41 - 60 of 63

Sort: Relevancy | Date

Presentation TCT 2018

LAA Closure 2: Step-by-step

Presenter: Habib Gamra, E. Murat Tuzcu, Hazem Khamis

September 23, 2018

Presentation TCT 2018

LAA Closure 1: State-of-the-art

Presenter: Habib Gamra, E. Murat Tuzcu

September 23, 2018

News Daily News

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Michael O'Riordan

August 06, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Conference News SCAI 2018

Longer Hospital Stays After TAVR Associated With Worse Outcomes

L.A. McKeown

April 27, 2018

News Conference News SCAI 2018

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

L.A. McKeown

April 26, 2018

News Daily News

Pulmonary Hypertension at Baseline Doesn’t Raise Mortality After TAVR

Caitlin E. Cox

April 20, 2018

News Daily News

The Biggest News of 2017: TCTMD’s Top 10

Shelley Wood

January 01, 2018

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

News Conference News PCR London Valves 2017

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

Shelley Wood

September 24, 2017

News Opinion Editor's Corner ESC 2017

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Shelley Wood

September 08, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

Presentation TCT 2016

Case Resolution: How Did We Treat this Patient?

Presenter: Nick Curzen, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

TAVR Restenosis: Review of the Literature

Presenter: Nick Curzen

October 31, 2016

Presentation TCT 2016

Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR

Presenter: Nick Curzen, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

TAVR for Intermediate-Risk and Low-Risk Patients: Review of the Literature

Presenter: Niall T. Mulvihill, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Presenter: Niall T. Mulvihill, Hellmuth Weich

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Presenter: Niall T. Mulvihill, Antoniette Neylon

October 31, 2016

Advertisement

LAA Closure 2: Step-by-step

LAA Closure 1: State-of-the-art

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Longer Hospital Stays After TAVR Associated With Worse Outcomes

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

Pulmonary Hypertension at Baseline Doesn’t Raise Mortality After TAVR

The Biggest News of 2017: TCTMD’s Top 10

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Off Script: Welcome to TCT 2017 in the Mile High City

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Case Resolution: How Did We Treat this Patient?

TAVR Restenosis: Review of the Literature

Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR

TAVR for Intermediate-Risk and Low-Risk Patients: Review of the Literature

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content